Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinoma.

Meyer T, Finn RS, Borad M, Mahipal A, Edeline J, Houot R, Hausner PF, Hollebecque A, Goyal L, Frigault M, Evans TRJ, Wong KM, Tan BR, Mitry E, Sarker D, Feun L, El-Rayes B, Thistlethwaite F, Kaseb A, Alese O, Jin Z, Cirillo C, Bruix J, Roddie C, Noto P, Fayngerts S, Cristiani S, Sampson J, Bai J, Isabelle M, Broad R, Sun A, Norry E, Sangro B

Open source

DOI: 10.1016/j.jhep.2025.07.033
Published: 2026 Jan
Container: Journal of hepatology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jhep.2025.07.033,
  title = {Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinoma.},
  author = {Meyer T and Finn RS and Borad M and Mahipal A and Edeline J and Houot R and Hausner PF and Hollebecque A and Goyal L and Frigault M and Evans TRJ and Wong KM and Tan BR and Mitry E and Sarker D and Feun L and El-Rayes B and Thistlethwaite F and Kaseb A and Alese O and Jin Z and Cirillo C and Bruix J and Roddie C and Noto P and Fayngerts S and Cristiani S and Sampson J and Bai J and Isabelle M and Broad R and Sun A and Norry E and Sangro B},
  year = {2026},
  journal = {Journal of hepatology},
  doi = {10.1016/j.jhep.2025.07.033},
  url = {https://doi.org/10.1016/j.jhep.2025.07.033}
}

RIS

TY  - JOUR
TI  - Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinoma.
AU  - Meyer T
AU  - Finn RS
AU  - Borad M
AU  - Mahipal A
AU  - Edeline J
AU  - Houot R
AU  - Hausner PF
AU  - Hollebecque A
AU  - Goyal L
AU  - Frigault M
AU  - Evans TRJ
AU  - Wong KM
AU  - Tan BR
AU  - Mitry E
AU  - Sarker D
AU  - Feun L
AU  - El-Rayes B
AU  - Thistlethwaite F
AU  - Kaseb A
AU  - Alese O
AU  - Jin Z
AU  - Cirillo C
AU  - Bruix J
AU  - Roddie C
AU  - Noto P
AU  - Fayngerts S
AU  - Cristiani S
AU  - Sampson J
AU  - Bai J
AU  - Isabelle M
AU  - Broad R
AU  - Sun A
AU  - Norry E
AU  - Sangro B
PY  - 2026
JO  - Journal of hepatology
DO  - 10.1016/j.jhep.2025.07.033
UR  - https://doi.org/10.1016/j.jhep.2025.07.033
ER  -

APA

T, M., RS, F., M, B., A, M., J, E., R, H., PF, H., A, H., L, G., M, F., TRJ, E., KM, W., BR, T., E, M., D, S., L, F., B, E., F, T., A, K., O, A., Z, J., C, C., J, B., C, R., P, N., S, F., S, C., J, S., J, B., M, I., R, B., A, S., E, N., & B, S. (2026). Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinoma.. Journal of hepatology. https://doi.org/10.1016/j.jhep.2025.07.033

Source records

pubmed · retrieved 2026-09-25T17:06:42.330Z